MedTrace Logo

Effect of Fluconazole on PK of Fluzoparib in Healthy Male Subjects

NCT04193319 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-12-10

No results posted yet for this study

Summary

The purpose of this study is to evaluate the Effect of fluconazole on the Pharmacokinetics of Fluzoparib in Healthy male Adults

Conditions

Interventions

DRUG

Fluzoparib

PARP inhibitor

DRUG

Fluconazole

inhibitor

Sponsors & Collaborators

  • Hunan Cancer Hospital

    collaborator OTHER

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-19
Primary Completion
2019-09-12
Completion
2019-09-12

Countries

  • China

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04193319 on ClinicalTrials.gov